United States Nootropics Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

The Global Nootropics Market reached USD 11,055.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 31,266.5 million by 2031. The global nootropics market is expected to exhibit a CAGR of 14.3% during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ October 2025 - BioAdaptives launched MyndMedTM, a cognitive-support detary supplements, available online. This product aims to enhance cognitive function and support overall brain health.

✅ July 2025 - BioAdaptives, Inc. announced the upcoming national launch of NeuroRushTM, an adaptogen-based nootropic supplement featuring ingredients like Rhodiola and Ashwagandha. The product is set to be available in both caffeinated and caffeine-free versions.

✅ July 2025 - Neutonic, a UK-based nootropic beverage startup, secured $3.7 million in its inaugural funding round, propelling its valuation to $20 million. This investment marks a significant milestone in the company's expansion into the U.S. market.

Japan: Recent Industry Developments

✅ October 2025 - BioAdaptives launched MyndMedTM in Japan, a cognitive-support dietary supplements available online. This marks the company's entry into the Japanese market, catering to the growing demand for brain health products.

✅ July 2025 - BioAdaptives, Inc. is preparing for the national launch of NeuroRushTM in Japan, following strong test-market results. The product will be offered in both caffeinated and caffeine-free versions, distributed via online and wellness partners.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nootropics-market?sb

Nootropics are substances that enhance cognitive functions such as memory, focus, creativity, and mental clarity. They include natural compounds, supplements, and synthetic drugs, widely used for brain health, neuroprotection, and improved mental performance.

Recent Mergers & Acquisitions

United States: Recent Mergers & Acquisitions

✅ October 2025 - HARKE Pharma acquired the Memory Complex, a patented nootropic blend developed by Green Bioactives, UK. This acquisition strengthens HARKE's portfolio in cognitive health supplements.

✅ September 2025 - LifeVantage announced the acquisition of LoveBiome's critical operating assets, expanding its leadership in direct sales and microbiome health and wellness.

✅ May 2025 - Sanofi acquired Vigil Neuroscience in a $470 million deal to bolster its neurological drug pipeline, particularly in Alzheimer's treatment.

Key Players:

=> Nootrobox, Inc., Purelife Bioscience Co. Ltd., Peak Nootropics, Nootrico, SupNootropic Biological Technology Co. Ltd., AlternaScript LLC, Accelerated Intelligence, Inc., Onnit Labs LLC, Powder City LLC, Ceretropic and Nootropic Source among others.

Growth Forecast Projected:

The Global Nootropics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Nootropics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nootropics-market

Key Segments:

➥ By Dosage Form: Tablets, Capsules, Injections, Powder, Drinks

➥ By Type: Over-the-Counter, Prescription

➥ By Application: Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-Aging, Sleep, Recovery and Dream Enhancement, Anxiety, Others

➥ By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Others

Regional Analysis for Nootropics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Nootropics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Nootropics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nootropics-market?sb

FAQ

What is the current size of the Nootropics Market?

A: In 2022, the Nootropics Market was valued at USD 11,055.5 million , reflecting its strong industry presence.

Q2: How large is the Nootropics Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Nootropics Market will grow to around USD 31,266.5 million , demonstrating significant expansion.

Q3: What is the growth rate of the Nootropics Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 14.3% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.